Drug recall
Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL). Rx only. The NDC number of the individual vial is…
FDA recall event 50183 · Class II · Teva Pharmaceuticals USA, Inc.
Key facts
| Event ID | 50183 |
|---|---|
| Recall numbers | D-167-2009 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Product type | Drugs |
| Products | Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL). Rx only. The NDC number of the individual vial is 0703-8315-01 and the NDC number for packages containing 10 vials is 0703-8315-03. The… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Exceeded Impurity Specifications |
| Initiation date | Oct 16, 2008 |
| Termination date | Aug 18, 2009 |
| City | Sellersville |
| State | PA |
| Country | United States |
| FEI number | 2517175 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports